Genetic Counseling for Patients with Non-Clear Cell RCC
The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.
Stay updated with breaking news from Mskcc Prognostic Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.
The panel discusses the best approaches to treating patients with non-clear cell RCC.
Mehmet Asim Bilen, MD, explains how he would treat a patient with renal cell carcinoma who had disease progression after adjuvant therapy.
The panel discusses recent clinical trial data in the adjuvant treatment of metastatic renal cell carcinoma.
The panel discusses the use of quality-of-life clinical trial data in metastatic renal cell carcinoma and how liver and brain metastases affect treatment decision-making.